Immunopharmacological approach to elucidating the mechanism of allergic inflammation

Allergology International

Volumn 54, Issue 2, 2005, Pages 251-261

  Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Allergic inflammation; Allergy; Anti allergic drug; Eosinophil; Mast cell

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CURCUMIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; FUCOSYLTRANSFERASE; GAMMA INTERFERON; HYDROXYPROLINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; LEUKOTRIENE; MATRIX METALLOPROTEINASE; MESSENGER RNA; NERVE GROWTH FACTOR; NEUTRALIZING ANTIBODY; OKT 4; PHOSPHODIESTERASE INHIBITOR; PIRPROFEN; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTANOID; PROTEIN P75; SPASMOLYTIC AGENT; STEM CELL FACTOR; STEROID; TACROLIMUS; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOXANE A2; THROMBOXANE RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC RHINITIS; ALLERGY; B LYMPHOCYTE; CLINICAL TRIAL; EOSINOPHIL; GENE; GENE EXPRESSION; HUMAN; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 21144455661     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.251     Document Type: Review

References (53)

1. Milian E, Diaz AM. Allergy to house dust mites and asthma. P. R. Health. Sci. J. 2004;23:47-57.
2. Gutman M, Torres A, Keen KJ, Houser SM. Prevalence of allergy in patients with chronic rhinosinusitis. Otolaryngol. Head Neck Surg. 2004;130:545-552.
3. Illi S, Von Mutius E, Lau S et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J. Allergy Clin. Immunol. 2004;113: 925-931.
4. Sampson HA. Update on food allergy. J. Allergy Clin. Immunol. 2004;113:805-819.
5. Ree-Kim L, Lehrer SB. Seafood allergy. Curr. Opin. Allergy Clin. Immunol. 2004;4:231-234.
6. Sterk PJ. Heterogeneity of airway hyperresponsiveness: time for unconventional but traditional, studies. J. Appl. Physiol. 2004;96:2017-2018.
7. Ren YH, Qin XQ, Guan CX et al. Temporal and spetial distribution of VIP, CGRP and their receptors in the development of airway hyperresponsiveness in the lungs. Sheng. Li. Xue. Bao. 2004;56:137-146.
8. Rickaeds KJ, Page CP, Cunningham FM. Allergen challenge alters lymphocyte phosphodiesterase activity in horses with heaves. Pulm. Pharmacol. Ther. 2004;17:163-172.
9. Lee KS, Jin SM, Kim SS, Lee YC. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. J. Allergy Clin. Immunol. 2004;113:902-909.
10. Lee AM, Fryer AD, Van Rooijen N, Jacoby DB. Role of macrophages in virus-induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction. Am. J. Physiol. Lung. Cell Mol. Physiol. 2004;286:1255-1259.
11. Nagai H, Tsuji F, Shimazawa T et al. Participation of collagenase and elastase in LPS-induced airway hyperresponsiveness in guinea pigs. Inflammation 1991;15:317-330.
12. Nagai H, Tsuji F, Goto S, Koda A. Pharmacological study of bacterial lipopolysaccharide-induced airway hyperresponsiveness in guinea-pigs. Arch. Int. Pharmacodyn. Ther. 1991;313:161-175.
13. Goto S, Nagai H, Inagaki N, Koda A. Pharmacological model for airway hypersensitivity produced by propranolol and reserpine in guinea pigs. Prostaglandins Leukot. Essent. Fatty Acids 1993;48:447-453.
14. 2)rexeptor antagonist(S-1452) on the antigen- induced bronchoconstriction and airway hyperresponsiveness in guinea pigs. Prostaglandins Leukot. Essent. Fatty Acids 1993;48:343-349.
15. Abe T, Yoshida K, Omata T et al. Effects of ZCR-2060 on allergic airway inflammation and cell activation in guinea-pigs. J. Pharm. Pharmacol. 1994;46:876-882.
16. Nagai H, Yamaguchi S, Tanaka H, Inagaki N. Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. Int. Arch. Allergy Immunol. 1995;108:189-195.
17. Uno T, Tanaka H, Nakai N, Nagai H. Participation of leukotriene D 4 and tumor necrosis factor on lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs. Biol. Phaem. Bull. 1997;20:332-337.
18. Takeda H, Kogame A, Tanaka H, Nagai H. Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs. Prostaglandins 1997;54:805-820.
19. Uno T, Tanaka H, Nagai H. Effects of isoenzyme selective phosphodiesterase inhibitors on bacterial lipopolysaccharide-induced bronchial hyperreactivity in guinea pigs. Gen. Pharmacol. 1998;30:167-173.
20. Kawada N, Tanaka H, Takizawa T et al. Role of mast cells in antigen-induced airway inflammation and bronchial hyperresponsiveness in rats. Jpn. J. Pharmacol. 2001;85:250-259.
21. Nagai H, Yamaguchi S, Inagaki N et al. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci. 1993; 53:243-247.
22. Yamaguchi S, Nagai H, Tanaka H et al. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci. 1994;54:471-475.
23. Nagai H, Yamaguchi S, Maeda Y, Tanaka H. Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice. Clin. Exp. Allergy 1996;26:642-647.
24. Nagai H, Yamaguchi S, Tanaka H. The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. Ann. N. Y. Acad. Sci. 1996;796:91-96.
25. Tanaka H, Kawada N, Yamada T et al. Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor alpha chain-deficient mice. Clin. Exp. Allergy 200;30:874-881.
26. Tokuoka S, Takahashi Y, Masuda T et al. Disruption of antigen-induced airway inflammation and airway hyperresponsiveness in low affinity neurotrophin receptor p 75 gene deficient mice. Br. J. Pharmacol. 2001;134:1580-1586.
27. Kawada N, Yamada T, Takahashi Y et al. The effect of leukotriene D(14)inhalation on the antigen-induced airway hyperresponsiveness and inflammation in 5-lipoxygenase gene- deficient mice. Int. Arch. Allergy Immunol. 2001; 126:309-317.
28. 2 as a mediator of allergic asthma. Science 2000;287:2013-2017.
29. Takahashi Y, Tokuoka S, Masuda T et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 2002;137:315-322.
30. Nagai H, Takeda H, Iwama T et al. Studies on anti-allergic action of AH 21-132, a novel isozymeselective phosphodiesterase inhibitor in airways. Jpn. J. Pharmacol. 1995;67: 149-156.
31. 2 receptor antagonist ON-579 on experimental allergic reactions. Prostaglandins Leukot. Essent Fatty Acids 1995;53:123-133.
32. Nagai H, Takeda H, Yamaguchi S et al. The effect of a thromboxane Pu. receptor antagonist BAY-u-3405 on experimental allergic reactions. Prostaglandins 1995;50:75-87.
33. Nagai H, Maeda Y, Tanaka H. The effect of anti-IL4 monoclonal antibody, rapamycin and interferon-gamma on airway hyperreactivity to acetylcholine in mice. Clin. Exp. Allergy 1997;27:218-224.
34. Tanaka H, Nagai H, Maeda Y. Effect of anti-IL-4 and anti-IL-5 antibody on allergic airway hyperresponsiveness in mice. Life Sci. 1998;62:169-174.
35. Musoh K, Maeda Y, Tanaka H et al. Effect of a novel anti-allergic agent, HSR-609, on antigen-induced airway hyperresponsiveness in mice. Pharmacology 2000;61:70-77.
36. Nagao K, Akabane H, Masuda T et al. Effect of MX-68 on airway inflammation and hyperresponsiveness in mice and guinea-pigs. J. Pharm. Pharmacol. 2004;56:187-196.
37. Inagaki N, Nagai H. Drugs for the treatment of allergic diseases. Jpn. J. Pharmacol. 2001;86:275-280.
38. Takahashi Y, Tokuoka S, Masuda T et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 2002;137:315-322.
39. Tanaka H, Komai M, Nagao K et al. Role of IL-5 and eosinophils in allergen-induced airway remodeling in mice. Am. J. Respir. Cell Mol. Biol. 2004;31:62-68.
40. Masuda T, Tanaka H, Komai M et al. Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin. Exp. Allergy 2003; 33:705-713.
41. Nagao K, Tanaka H, Komai M et al. Role of prostaglandin 12 in airway remodeling induced by repeated allergen challenge in mice. Am. J. Respir. Cell Mol. Biol. 2003;29: 314-320.
42. Komai M, Tanaka H, Masuda T et al. Role of Th2 responses in the development of allergen-induced airway remodeling in a murine model of allergic asthma. Br. J. Pharmacol. 2003;138:912-920.
43. Tanaka H, Masuda T, Tokuoka S et al. Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling. Inflamm. Res. 2002;51:307-316.
44. Tanaka H, Masuda T, Tokuoka S et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm. Res. 2001;50:616-624.
45. Nagai H, Hiyama H, Matsuo A et al. FK-506 and cyclosporine A potentiate the IgE antibody production by contact sensitization with hapten in mice. J. Pharmacol. Exp. Ther. 1997;283:321-327.
46. Nagai H, Matsuo A, Hiyama H et al. Immunoglobulin E production in mice by means of contact sensitization with a simple chemical hapten. J. Allergy Clin. Immunol. 1997; 100:39-44.
47. Nagai H, Ueda Y, Tanaka H et al. Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice. J. Pharmacol. Exp. Ther. 1999;288:43-50.
48. Nagai H, Inagaki N, Tanaka H. Role of IgE for the onset of allergic cutaneous response caused by simple chemical hapten in mice. Int. Arch. Allergy Immunol. 1999;118:285-286.
49. Togawa M, Kiniwa M, Nagai H. The roles of IL-4, IL-5 and mast cells in the accumulation of eosinophils during allergic cutaneous late phase reaction in mice. Life Sci. 2001; 69:699-705.
50. Kimata M, Inagaki N, Nagai H. Effects of luteolin and other flavonoids on IgE-mediates allergic reactions. Planta. Med. 2000;66:25-29.
51. Nagai H, Ueda Y, Ochi T et al. Different role of IL4 in the onset of hapten-induced contact hypersensitivity in BALB/c and C57BL/6 mice. Br. J. Pharmacol. 2000;129: 299-306.
52. Ueda Y, Sone T, Inagaki N, Nagai H. Effects of prednisolone on the cutaneous reaction and skin barrier function in mice treated with a hapten. Biol. Pharm. Bull. 2003;26: 618-621.
53. 2 modulates interaction of dendtritic cells and T cells and regulates acquired immunity. Nat. Immunol. 2003;4:694-701.